29 HRSA-funded health centers to receive boost in technology to improve outcomes
The Department of Health and Human Services awarded nearly $55 million to 29 government-funded health centers to increase health care access and quality for underserved populations through virtual care, such as telehealth, remote patient monitoring, digital patient tools, and health information technology platforms.
This funding builds on more than $7.3 billion in American Rescue Plan funding invested in community health centers over the past year to help mitigate the impact of COVID-19.
“Virtual care has been a game-changer for patients, especially during the pandemic,” said HHS Secretary Xavier Becerra in a statement. “This funding will help health centers leverage the latest technology and innovations to expand access to quality primary care for underserved communities.”
In response to the COVID-19 pandemic, health centers have quickly expanded their use of virtual care to maintain access to essential primary care services. They reported significant growth in the number of virtual visits from 478,333 in 2019 to 28,550,608 in 2020, a 6,000% increase. In total, the number of health centers offering virtual visits grew from 592 in 2019 to 1,362 in 2022, an increase of 130%.
The more than 1,400 HRSA-supported health centers serve as a national source of primary care for at-risk communities. They are community-based and patient-directed organizations that deliver medical, dental, and behavioral health services to nearly 29 million patients each year. As of late January, overall health centers have delivered over 19.2 million vaccine doses, with 68 percent going to racial or ethnic minority patients. More than 90 percent of health center patients are individuals or families living at or below 200 percent of the Federal Poverty Guidelines (about $55,000 per year for a family of four in most states) and approximately 62 percent are racial/ethnic minorities.
This article was originally published by sister publication Medical Economics.
Fluoxetine helps refractory nocturnal enuresis but not for long
March 29th 2023A 12-week study in Egypt of the efficacy of fluoxetine (a selective serotonin reuptake inhibitor) in children with treatment-refractory nocturnal enuresis (NE) found that though the treatment achieved a good initial response, it was not sustainable.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Are some patients predisposed to avascular necrosis after hip surgery?
March 14th 2023Although avascular necrosis (AVN) is believed to be an iatrogenic complication following treatment of developmental dysplasia of the hip, an investigation in China found 2 characteristics associated with the condition: the likelihood of AVN increases with both the grade of dislocation and of underdevelopment of the ossific nucleus.
Meet the board: Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
April 22nd 2022In the latest episode of our podcast series, Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN shares why she got into medicine, the myths of pediatric, and what the future may hold for the specialty.